Executive Team

Dr. Fallon brings to Curemark visionary science and its application to multiple disease targets. Having filed her first patent application in 1999, Dr. Fallon has worked to research autism and related disorders as well as to bring her findings to a platform for commercialization.

Dr. Fallon has both clinical and academic experience. As a seasoned clincian, she worked as a pediatric chiropractor for 25 years specializing in pediatric development. She taught anatomy, physiology and developmental biology as an assistant professor of natural science and mathematics at Yeshiva University, in addition to lecturing about pedictaric development around the world. Dr. Fallon served on the advisory board for Oxford health plans, as well as on the boards of numerous not for profits.

Dr. Fallon’s discovery of the biomarker for autism and ADHD and her vast array of the intellectual property in the area of gastrointestinal secretory deficiencies, forms the basis of Curemark. As a pediatric specialist she was one of the first physicians of any type to enter Romania and to help determine the state of the Romanian orphanages. She served as an advisor to the NewYork Yankees for disability services for the new Yankee Stadium. She has a BA degree from Franklin and Marshall College, a DC degree from Palmer University, and has completed her work for the MSc in clinical investigation from Harvard University’s joint program with Massachusetts General Hospital. She resides in Bronxville, NY.

As Senior Vice President of Operations, Dr. Zinberg is responsible for the day-to-day management of Curemark and the implementation of the company’s strategic plan and clinical program. Additionally, Dr. Zinberg is responsible for overseeing the company’s multi-million dollar clinical program, as it undertakes the largest clinical trial ever conducted for autism. Among other things her duties include the recruitment of the major universities in the United States and abroad who are participating in Curemark’s clinical trials program.

Previously, Dr. Zinberg held the position of Chief Operating Officer at The Masters Circle, Inc. where, under her leadership, the previously small, privately held practice management and leadership development company for chiropractors grew into a multimillion-dollar worldwide business. Prior to The Masters Circle, Dr. Zinberg was in private practice for more than a decade running a high-volume, family-based natural health care practice. Her unique style of leadership and expertise has earned her a well-merited reputation as one of the top female executives and consultants in America.

Dr. Zinberg received her Bachelors degree from Franklin and Marshall College and her Doctor of Chiropractic degree from New York Chiropractic College.

Matthew Heil, Ph.D., Senior Vice President of Research and Development, manages all aspects of drug development and manufacturing for Curemark. Trained as an immunologist, Dr. Heil joined the company in 2006.

Previously, Dr. Heil served as Vice President for Development Operations at Auriga Laboratories, Inc. in Atlanta. He spent the prior 15 years as a Pharmaceutical Development Consultant with the Delphi Group, Ltd. and BioInnovators, Ltd. in White Plains, New York.

Dr. Heil was a member of the Faculty Of Medicine at New York Medical College and Co-Director of the Immunotype Clinical Laboratory at Westchester County Medical Center.

Subsequent to his career in research, Dr. Heil gained a broad range of experience working with top-level management in the pharmaceutical and biotechnology industries providing product valuation, technical due diligence, strategic partnering as well as probabilistic modeling for epidemiological analysis, sales projection and market evaluation. Dr. Heil has worked with both small biotechnology companies, as well as most of the major pharmaceutical firms.